Docality.com Logo
 
Dr. Smriti  Sharma  Md image

Dr. Smriti Sharma Md

1445 Whitehorse Mercerville Rd Suite 103
Hamilton NJ 08619
609 876-6661
Medical School: Other - 1989
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: Yes
Participates In EHR: Yes
License #: 25MA07430900
NPI: 1508817008
Taxonomy Codes:
207R00000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Smriti Sharma is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:93000 Description:Electrocardiogram complete Average Price:$95.00 Average Price Allowed
By Medicare:
$20.59
HCPCS Code:Q2038 Description:Fluzone vacc, 3 yrs & >, im Average Price:$30.00 Average Price Allowed
By Medicare:
$12.16
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$128.00 Average Price Allowed
By Medicare:
$110.52
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$89.00 Average Price Allowed
By Medicare:
$74.92
HCPCS Code:G0008 Description:Admin influenza virus vac Average Price:$30.00 Average Price Allowed
By Medicare:
$26.58

HCPCS Code Definitions

93000
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
G0008
Administration of influenza virus vaccine
Q2038
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1336127380
Cardiovascular Disease (Cardiology)
539
1386622769
Cardiac Electrophysiology
286
1487631909
Internal Medicine
198
1245236264
Diagnostic Radiology
198
1083665558
Internal Medicine
198
1922078195
Endocrinology
169
1174551071
Diagnostic Radiology
147
1710983507
Diagnostic Radiology
147
1164492385
Cardiovascular Disease (Cardiology)
136
1780647552
Cardiovascular Disease (Cardiology)
128
*These referrals represent the top 10 that Dr. Sharma has made to other doctors

Publications

Prebiotics and Lipid Metabolism: A Review. - Alternative therapies in health and medicine
Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide. Modifiable risk factors of CHD have been identified, including high levels of low-density lipoproteins (LDLs) and triglycerides (TGs). Attempts by various researchers have been made to alter them. Several approaches, both pharmacological and nonpharmacological, have been identified to deal with the soaring numbers of individuals with those high levels. Current CHD treatment includes dietary interventions and use of statins, fibrates, niacin, cholesterol absorption inhibitors, and bile acid sequestrants. Those formulations have limitations and can possess long-term, unwanted side effects, and, therefore, other cholesterol-lowering, dietary adjuncts need to be identified and supplemented. Prebiotics are indigestible, fermented food substrates that selectively stimulate the growth and increase the activity of 1 or a limited number of microbial genus species, thereby changing the composition of the gut microbiota to confer health benefits to the hosts. Prebiotics are also nondigestible carbohydrates with specific fermentative properties, stimulating specific microbial growth associated with health and well-being. Some animal and human studies have provided strong evidence that suggests that prebiotics, as functional foods, can positively alter an individual's serum lipid profile, thereby lowering his or her risk of developing CHD. Therefore, the current review focuses on evaluating the role of prebiotics as potential dietary adjuncts in lowering cholesterol levels, with the aim of reducing the risks of cardiovascular and CHD.
Molecular dynamics simulations indicate that tyrosineB10 limits motions of distal histidine to regulate CO binding in soybean leghemoglobin. - Proteins
Myoglobin (Mb) uses strong electrostatic interaction in its distal heme pocket to regulate ligand binding. The mechanism of regulation of ligand binding in soybean leghemoglobin a (Lba) has been enigmatic and more so due to the absence of gaseous ligand bound atomic resolution three-dimensional structure of the plant globin. While the 20-fold higher oxygen affinity of Lba compared with Mb is required for its dual physiological function, the mechanism by which this high affinity is achieved is only emerging. Extensive mutational analysis combined with kinetic and CO-FT-IR spectroscopic investigation led to the hypothesis that Lba depended on weakened electrostatic interaction between distal HisE7 and bound ligand achieved by invoking B10Tyr, which itself hydrogen bonds with HisE7 thus restricting it in a single conformation detrimental to Mb-like strong electrostatic interaction. Such theory has been re-assessed here using CO-Lba in silico model and molecular dynamics simulation. The investigation supports the presence of at least two major conformations of HisE7 in Lba brought about by imidazole ring flip, one of which makes hydrogen bonds effectively with B10Tyr affecting the former's ability to stabilize bound ligand, while the other does not. However, HisE7 in Lba has limited conformational freedom unlike high frequency of imidazole ring flips observed in Mb and in TyrB10Leu mutant of Lba. Thus, it appears that TyrB10 limits the conformational freedom of distal His in Lba, tuning down ligand dissociation rate constant by reducing the strength of hydrogen bonding to bound ligand, which the freedom of distal His of Mb allows. Proteins 2015; 83:1836-1848. © 2015 Wiley Periodicals, Inc.© 2015 Wiley Periodicals, Inc.
3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase. - Bioorganic chemistry
Ligand-based and structure-based methods were applied in combination to exploit the physicochemical properties of 2,3-dideoxy hex-2-enopyranosid-4-uloses against Mycobacterium tuberculosis H37Rv. Statistically valid 3D-QSAR models with good correlation and predictive power were obtained with CoMFA steric and electrostatic fields (r(2) = 0.797, q(2) = 0.589) and CoMSIA with combined steric, electrostatic, hydrophobic and hydrogen bond acceptor fields (r(2) = 0.867, q(2) = 0.570) based on training set of 33 molecules with predictive r(2) of 0.808 and 0.890 for CoMFA and CoMSIA respectively. The results illustrate the requirement of optimal alkyl chain length at C-1 position and acceptor groups along hydroxy methyl substituent of C-6 to enhance the anti-tubercular activity of the 2,3-dideoxy hex-2-enopyranosid-4-uloses while any substitution at C-3 position exert diminishing effect on anti-tubercular activity of these enulosides. Further, homology modeling of M. tuberculosis alpha-mannosidase followed by molecular docking and molecular dynamics simulations on co-complexed models were performed to gain insight into the rationale for binding affinity of selected inhibitors with the target of interest. The comprehensive information obtained from this study will help to better understand the structural basis of biological activity of this class of molecules and guide further design of more potent analogues as anti-tubercular agents.Copyright © 2015 Elsevier Inc. All rights reserved.
Oral Crohn's disease. - Journal of oral and maxillofacial pathology : JOMFP
'Crohn's disease' is an inflammatory granulomatous disease of the gastrointestinal tract with extra-intestinal manifestations. Oral lesions may precede the intestinal disease and serve as a source for histological diagnosis. We present a case of orofacial Crohn's disease where orofacial symptoms were present for about 13 years and occasional constipation was present, since 6 months. Oral examination plays an important role in early diagnosis of Crohn's disease.
Biodegradation of imidacloprid by consortium of two soil isolated Bacillus sp. - Bulletin of environmental contamination and toxicology
Imidacloprid degradation potential of bacterial cultures from sugarcane growing soils was studied in liquid culture and Bacillus aerophilus and Bacillus alkalinitrilicus showed maximum potential to degrade imidacloprid. Hence, into a clay loam soil imidacloprid was added at 50, 100, and 150 mg kg(-1) along with 45 × 10(7) cells g(-1) soil of both species under autoclaved and unautoclaved conditions. Under autoclaved conditions imidacloprid residues were degraded after 56 days to 3.18, 5.83 and 10.48 mg kg(-1) and under unautoclaved conditions to 5.17, 6.23 and 10.31 mg kg(-1). 6-chloronicotinic acid, nitrosimine and imidacloprid-NTG metabolites were detected in measurable concentrations under both conditions. Dissipation pattern of imidacloprid did not follow first order kinetics under both sets of conditions. The half life value of imidacloprid ranged from 13 to 16 days after bacterial inoculation. This is first report of use of mixed culture of native soil bacterial isolates for remediation of imidacloprid contaminated soils.
Sensitive methodology for simultaneous determination of residues of imidacloprid and its metabolites in sugarcane leaves and soil. - Journal of AOAC International
An analytical method to quantify imidacloprid and its metabolites in sugarcane leaves and soil using HPLC has been developed. The samples were extracted with acetonitrile + water (80 + 20, v/v), soil samples partitioned with dichloromethane, and leaf samples with hexane + ethyl acetate (9 + 1, v/v) and dichloromethane. Further, the extracts were dried, filtered, and concentrated under vacuum into HPLC-grade acetonitrile. Residues were estimated using an HPLC equipped with a photodiode array detector system, C18 column with a mobile phase of acetonitrile + water (40 + 60, v/v) at 0.3 mL/min to separate imidacloprid and its six metabolites in single run of 20 min. The mean percent recoveries of imidacloprid and its metabolites ranged from 80.45 to 99.80 from sugarcane leaves and 80.20 to 99.70 from sugarcane soils. The analytical method was validated in terms of selectivity, linearity, reproducibility, repeatability, and accuracy. The repeatability values ranged from 0.24 to 3.15% and 1.69 to 4.94%, along with 2.73 to 3.82% and 1.12 to 4.96%, for imidacloprid and its metabolites in leaves and soil, respectively. The reproducibility of imidacloprid and its metabolites in leaves and soil ranged from 2.20 to 4.27% and 2.53 to 4.08%, respectively, and all measurements were within 15% at all concentration levels.
Advances in our understanding of mechanisms of venous thrombus resolution. - Expert review of hematology
Traditionally, venous thrombosis has been seen as the consequence of a regulated cascade of proteolytic steps leading to the polymerization of fibrinogen and fibrin crosslinking that is facilitated by platelets. A new view of thrombosis is providing a more integrated concept, with components of the vascular wall contributing to the vascular remodeling of thrombosis. Angiogenesis and inflammation are two key mechanisms that safeguard venous thrombus resolution and restitution of vascular patency after thrombosis. Disturbance of these processes leads to thrombus persistence and has potentially severe consequences for affected patients. Examples for clinical conditions associated with recurrent or persisting venous thrombosis are post-thrombotic syndrome or chronic thromboembolic pulmonary hypertension. Recently, studies using animal models of venous thrombosis have contributed to a better understanding of thrombus non-resolution that will eventually lead to modification of current treatment concepts. For example, recent data suggest that innate immunity is involved in the modification of thrombosis.
Assessment of imidacloprid degradation by soil-isolated Bacillus alkalinitrilicus. - Environmental monitoring and assessment
Imidacloprid is extensively used on a broad range of crops worldwide as seed dressing, soil treatment, and foliar application. Hence, the degradation potential of bacterial strains from sugarcane-growing soils was studied in liquid medium for subsequent use in bioremediation of contaminated soils. The microbe cultures degrading imidacloprid were isolated and enriched on Dorn's broth containing imidacloprid as sole carbon source maintained at 28 °C and Bacillus alkalinitrilicus showed maximum potential to degrade imidacloprid. Clay loam soil samples were fortified with imidacloprid at 50, 100, and 150 mg kg(-1) along with 45 × 10(7) microbe cells under two opposing sets of conditions, viz., autoclaved and unautoclaved. To study degradation and metabolism of imidacloprid under these two conditions, samples were drawn at regular intervals of 7, 14, 28, 35, 42, 49, and 56 days. Among metabolites, three metabolites were detected, viz., 6-chloronicotinic acid, nitrosimine followed by imidacloprid-NTG under both the conditions. Total imidacloprid residues were not found to follow the first-order kinetics in both types of conditions. This paper reports for the first time the potential use of pure cultures of soil-isolated native bacterium B. alkalinitrilicus and also its use along with natural soil microflora for remediation of imidacloprid-contaminated soils.
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents. - European journal of medicinal chemistry
Here, we describe a molecular hybridization inspired design and synthesis of novel 6-triazolyl 2,3,6-trideoxy sugars as promising new broad-spectrum antimicrobial agents using click chemistry in key step. These compounds showed MIC between 0.39 and 50 μg/mL against different native and resistant bacteria and fungi with no toxicity. Among them, compound 29 was the most active molecule with MIC 0.78 μg/mL against Staphylococcus aureus and Klebsiella pneumoniae and 3.12 μg/mL against methicillin- and vancomycin-resistant S. aureus. Compound 26 was the most potent anti-fungal candidate with MIC 0.39 μg/mL against Trichophyton mentagrophytes. Compound 46 was found to be promising with broad-spectrum activity against both bacterial and fungal strains. The bioinformatic studies involving bacteria's protein co-crystals prompted penicillin binding protein-2 as the most likely target of these compounds.Copyright © 2014 Elsevier Masson SAS. All rights reserved.
Deoxysugars as antituberculars and alpha-mannosidase inhibitors. - Antimicrobial agents and chemotherapy
A promising modified sugar molecule was identified which was active against multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, suggesting involvement of a new target. The compound was demonstrated to be bactericidal, inhibited the growth of M. tuberculosis in mice, and targeted alpha-mannosidase as a competitive inhibitor with a Ki value of 353.9 μM.Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Map & Directions

1445 Whitehorse Mercerville Rd Suite 103 Hamilton, NJ 08619
View Directions In Google Maps

Nearby Doctors

2333 Whitehorse Mercerville Rd Suite 5
Mercerville, NJ 08619
609 880-0500
1542 Kuser Rd Suite B7
Trenton, NJ 08619
609 811-1400
1401 Whitehourse-Mercerville Road Suite 219
Hamilton, NJ 08619
609 845-5150
1 Quakerbridge Plz
Trenton, NJ 08619
609 868-8080
2275 Whitehorse Mercerville Rd
Mercerville, NJ 08619
609 900-0200
3705 Quakerbridge Rd Suite 203
Hamilton, NJ 08619
609 866-6688
1445 Whitehorse Mercerville Rd Suite 103
Hamilton, NJ 08619
609 876-6661
1755 Klockner Rd
Hamilton, NJ 08619
609 870-0083
1225 Whitehorse Mercerville Rd Bldg. D, Suite 220
Mercerville, NJ 08619
609 812-2200
2333 Whitehorse Mercerville Rd Suite 8
Mercerville, NJ 08619
609 880-0540